# K073356: Paradigm Insulin Infusion Pump, Models MMT-512, MMT-712, MMT-515 and MMT-715

- Pathway: 510(k) (Special)
- Applicant: Medtronic Minimed
- Decided: Apr 25, 2008 after 148 days
- Product code: LZG (Pump, Infusion, Insulin)
- Device class: 2
- Regulation: 21 CFR 880.5725
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 1 cites it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K090245: Solo Insulin Patch Pump (2009), 1 descendant of its own
- K093364: Solo Micropump Insulin Delivery System (2010), 0 descendants of its own

## Indications for use
The Medtronic MiniMed Paradigm Model MMT-512, MMT-712, MMT-515 and MMT-715 insulin infusion pumps are indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin.

Source page: https://510kreport.com/device/K073356
Methodology: https://510kreport.com/methodology